Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy
Clinical trial NCT05794139 · COMPLETED
Trial details
- NCT number
- NCT05794139
- Sponsor
- NMD Pharma A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2026-05-11
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.